0001062993-23-021522.txt : 20231128
0001062993-23-021522.hdr.sgml : 20231128
20231128162536
ACCESSION NUMBER: 0001062993-23-021522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231127
FILED AS OF DATE: 20231128
DATE AS OF CHANGE: 20231128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Michael Gerard
CENTRAL INDEX KEY: 0001934174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 231446798
MAIL ADDRESS:
STREET 1: C/O COMERA LIFE SCIENCES HOLDINGS, INC.
STREET 2: 12 GILL STREET, SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-11-27
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001934174
Campbell Michael Gerard
C/O COMERA LIFE SCIENCES HOLDINGS, INC.
12 GILL STREET, SUITE 4650
WOBURN
MA
01801
0
1
0
0
EVP & CFO
0
Common Stock
2023-11-27
4
P
0
10000
0.0708
A
35000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0675 to $0.07125, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
2023-11-28